MOSCOW (MRC) -- Shares of the specialty chemicals company Evonik Industries AG will be added to the Morgan Stanley Capital International (MSCI) World and Germany Indexes effective June 1, 2015, reported the producer on its site.
MSCI announced the results of the May 2015 Annual Index Review yesterday night. The inclusion follows the recent placements of shares by a major shareholder of Evonik.
MSCI offers a family of consistent and comparable indexes which comprise the world’s largest companies and are broadly used by investors around the world to develop and benchmark their global equity portfolios.
Ute Wolf, CFO of Evonik, comments: "Evonik’s inclusion to the MSCI Indexes enhances our presence in the most important indexes globally. This means greater visibility for Evonik at the international financial markets and will further increase the high level of interest from global investors in our share. Even more motivated by the MSCI inclusion, we will continue our capital market oriented approach and further intensify our dialogue with international investors."
As MRC informed earlier, Evonik has strengthened its technology platform for specialty silicones with a global investment initiative, since demand for additives for the construction, textile, coating, furniture, and appliance industries is driving the global market growth for specialty silicones. Overall, Evonik plans to invest a triple-digit-million-euro amount in the coming years and gradually increase the production volume of specialty silicones.
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms. Evonik is active in over 100 countries around the world. In fiscal 2014 more than 33,000 employees generated sales of around EUR12.9 billion and an operating profit (adjusted EBITDA) of about EUR1.9 billion.
MRC